Back to All NewsCartessa Aesthetics Adds Industry Veteran Chris Aronson to Executive Team
Posted By American Med Spa Association, Thursday, July 30, 2020
Share
In just three years, Cartessa Aesthetics has grown to be a significant player in the aesthetics industry. To continue to fuel this rapid growth, Cartessa Aesthetics announced today that Chris Aronson will be joining the company’s executive team as chief commercial officer. In this role, Aronson will lead the strategic expansion into new verticals and support the company's portfolio of products, which includes the new RF Microneedling Platform VirtueRF, the CoolPeel by Tetra CO2 treatment and at least two more launches planned for 2020.
Aronson brings to Cartessa 20 years of sales and management experience in the medical device industry. Having joined Cynosure in 2003, Aronson held various positions in his 14-year tenure with Cynosure, including his final role as Executive Vice President of North American Sales overseeing yearly revenue in excess of $200 million, a 100+ person commercial team, and multiple product launches and company acquisitions. After leaving Cynosure, Aronson introduced the Artas iX Robot and built the North American sales force for Restoration Robotics and planned the launch the Elipse Intragastric balloon for Allurion in North America and Australia (pending FDA approval).
Read more at Cartessa Aesthetics >>
Aronson brings to Cartessa 20 years of sales and management experience in the medical device industry. Having joined Cynosure in 2003, Aronson held various positions in his 14-year tenure with Cynosure, including his final role as Executive Vice President of North American Sales overseeing yearly revenue in excess of $200 million, a 100+ person commercial team, and multiple product launches and company acquisitions. After leaving Cynosure, Aronson introduced the Artas iX Robot and built the North American sales force for Restoration Robotics and planned the launch the Elipse Intragastric balloon for Allurion in North America and Australia (pending FDA approval).
Read more at Cartessa Aesthetics >>
